This Nature article highlights how blood-based biomarkers for Alzheimer’s disease stand to have the potential to transform diagnostics, and how new treatments and therapies are developed. There is mention of how Bio-Hermes-001, and Bio-Hermes-002, use head-to-head comparisons of blood-based biomarkers and digital tests to explore which combinations of blood-based biomarkers perform best across different populations and disease stages.
Read more here: https://www.nature.com/articles/d41591-026-00008-4#author-0
Nature: Blood tests for Alzheimer’s disease could reshape research and care
